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Abstract
We report here the utility of major histocompatibility complex (MHC) class II dextramers for in situ detection of self-reactive
CD4 T cells in two target organs, the brain and heart. We optimized the conditions for in situ detection of antigen-specific
CD4 T cells using brain sections obtained from SJL mice immunized with myelin proteolipid protein (PLP) 139–151; the
sections were costained with IAs/PLP 139–151 (specific) or Theiler’s murine encephalomyelitis virus (TMEV) 70–86 (control)
dextramers and anti-CD4. Analysis of sections by laser scanning confocal microscope revealed detection of cells positive for
PLP 139–151 but not for TMEV 70–86 dextramers to be colocalized with CD4-expressing T cells, indicating that the staining
was specific to PLP 139–151 dextramers. Further, we devised a method to reliably enumerate the frequencies of antigen-
specific T cells by counting the number of dextramer+ CD4+ T cells in the ‘Z’ serial images acquired sequentially. We next
extended these observations to detect cardiac myosin-specific T cells in autoimmune myocarditis induced in A/J mice by
immunizing with cardiac myosin heavy chain-a (Myhc) 334–352. Heart sections prepared from immunized mice were
costained with Myhc 334–352 (specific) or bovine ribonuclease 43–56 (control) dextramers together with anti-CD4; the
sections showed the infiltrations of Myhc-specific CD4 T cells. The data suggest that MHC class II dextramers are useful tools
for enumerating the frequencies of antigen-specific CD4 T cells in situ by direct staining without having to amplify the
fluorescent signals, an approach commonly employed with conventional MHC tetramers.
Citation: Massilamany C, Gangaplara A, Jia T, Elowsky C, Kang G, et al. (2014) Direct Staining with Major Histocompatibility Complex Class II Dextramers Permits
Detection of Antigen-Specific, Autoreactive CD4 T Cells In Situ. PLoS ONE 9(1): e87519. doi:10.1371/journal.pone.0087519
Editor: Robert Shin Fujinami, University of Utah School of Medicine, United States of America
Received September 17, 2013; Accepted December 23, 2013; Published January 27, 2014
Copyright:  2014 Massilamany et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the American Heart Association and the Children’s Cardiomyopathy Foundation (SDG2462390204001), and the National
Institutes of Health (HL114669). CM is a recipient of a postdoctoral research fellowship grant awarded by the Myocarditis Foundation, NJ. The funders had no role
in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: nreddy2@unl.edu
. These authors contributed equally to this work.
Introduction
Traditionally, limiting dilution analysis, enzyme-linked immu-
nosorbent spot assay, intracellular cytokine staining, and cytokine-
secretion assay have been used to enumerate frequencies of
antigen-specific T cells [1–7]. While all these are functional assays,
they provide information largely at the population level.
Additionally, low specificity and the laborious nature of these
assays may limit their use for routine applications [1–5]. To
overcome these limitations, and to be able to phenotype the
antigen-specific T cells at a single cell level, major histocompat-
ibility complex (MHC) tetramer technology has been developed
[8]. The use of tetramers has revolutionized our understanding of
the nature of immune responses with respect to the appearance,
disappearance and/or persistence of antigen-specific T cells in
experimental and clinical conditions [5,9].
While MHC class I tetramers permit detection of antigen-
specific CD8 T cells, MHC class II tetramers are used to analyze
CD4 T cell responses. Detection of antigen-specific CD4 T cells
using MHC class II tetramers, however, is particularly challenging
compared to using MHC class I tetramers [5,9–14]. Several
factors contribute to this disparity: 1) low affinity of MHC class II/
peptide complexes; 2) low affinity of T cell receptors (TCRs) for
MHC/peptide complexes; 3) instability of soluble MHC class II
monomers in in vitro expression systems; 4) improper registry and
geometry of peptides for display by MHC molecules; 5) lack of
participation of CD4 coreceptors in MHC-binding; and 6)
activation-dependency [13,15–18]. In our efforts to improve the
sensitivity of MHC class II tetramers, we recently created next-
generation tetramers, designated ‘‘dextramers.’’ The dextramer
reagents proved helpful in enumerating the frequencies of
autoreactive CD4 T cells in several murine autoimmune disease
models as evaluated by flow cytometry [19].
Structurally, dextramers contain dextran backbones, which are
polymers of glucose molecules attached through 1–6 and 1–3
linkages [20]. Each dextran molecule carries multiple moieties of
streptavidin to which biotinylated peptide-tethered MHC mole-
cules can be assembled [20]. As a result, MHC dextramers contain
PLOS ONE | www.plosone.org 1 January 2014 | Volume 9 | Issue 1 | e87519
aggregates of MHC-peptide complexes, allowing them to engage
multiple TCRs – more than that could be achieved with tetramers.
Using three different autoimmune disease models 2 myelin
proteolipid protein (PLP) 139-151-induced experimental autoim-
mune encephalomyelitis (EAE) in SJL mice; myelin oligodendro-
cyte glycoprotein (MOG) 35-55-induced EAE in C57Bl/6 mice;
and cardiac myosin heavy chain-a (Myhc) 334-352-induced
experimental autoimmune myocarditis (EAM) in A/J mice 2 we
demonstrated that the MHC class II dextramers were at least five-
fold more sensitive than the tetramers, and their specificity was
also superior [19]. In this study, using PLP 139-151-induced EAE
and Myhc 334-352-induced EAM models, we report that MHC
class II dextramers can be successfully used to detect autoreactive
CD4 T cells in situ with a high degree of specificity by direct
staining without the need to amplify the signals with fluorophore
antibodies, which is generally required with tetramers. We also
describe a comprehensive method of evaluating tissues to
accurately enumerate the frequencies of antigen-specific CD4 T
cells in situ.
Materials and Methods
Ethics statement
Five-to-six-week-old female SJL/J (H-2s) and six-to-eight-week-
old female A/J mice were obtained from the Jackson Laboratory
(Bar Harbor, ME, USA). The mice were maintained in
accordance with the animal protocol guidelines of the University
of Nebraska-Lincoln, Lincoln, NE, USA. The study was conduct-
ed in accordance with National Institutes of Health guidelines for
the use of experimental animals, and the protocols were
specifically approved by The University of Nebraska-Lincoln
Institutional Animal Care and Use Committee (permit number:
A3459-01; protocol # 659 and 615).
Peptide synthesis and immunization procedures
PLP 139–151 (HSLGKWLGHPDKF), and Myhc 334–352
(DSAFDVLSFTAEEK AGVYK) were synthesized on 9-fluore-
nylmethyloxycarbonyl chemistry (Neopeptide, Cambridge, MA,
USA). All peptides were HPLC-purified (.90%), identity-
confirmed by mass spectroscopy, and dissolved in sterile 16 PBS
prior to use. Peptides were then emulsified in complete Freund’s
adjuvant (CFA) supplemented with Mycobacterium tuberculosis (Mtb)
H37RA extract (Difco Laboratories, Detroit, MI, USA) to a final
concentration of 5 mg/ml, and the emulsions were administered
s.c. to induce EAE or EAM as we have described previously
[19,21,22]. To generate primary T cell cultures, peptides
emulsified in CFA containing Mtb (1 mg/ml) were administered
s.c. (100 mg/mouse) as described previously [19,22].
Clinical scoring and collection of tissues for in situ
staining
SJL mice immunized with PLP 139–151 were monitored for
clinical signs of EAE and scored as described previously [22,23].
The animals reaching scores of 3 and above were euthanized using
a prefilled CO2 chamber, and the left ventricles of their hearts
were perfused with 10 ml of cold 16PBS. Cerebrums were gently
excised by blunt dissection and placed in cold 16PBS. Similarly,
on day 21 postimmunization with Myhc 334–352, A/J mice were
euthanized and perfused as above, and hearts were collected and
placed in cold 16 PBS.
Generation of MHC class II dextramers
IAs dextramers (PLP 139–151 and Theiler’s murine encepha-
lomyelitis virus [TMEV] 70–86) and IAk dextramers (Myhc 334–
352 and bovine ribonuclease [RNase] 43–56) were generated as
we have described previously [19]. Briefly, a and b constructs for
each IA allele containing the sequences of the respective peptides
were expressed in baculovirus using Sf9 insect cells (Invitrogen,
Carlsbad, CA), and the soluble monomers of IAs and IAk were
purified [22,24,25]. After being concentrated, the soluble MHC
class II proteins were biotinylated using biotin protein ligase at an
optimized concentration of 25 mg/10 nmol of substrate as
recommended by the manufacturer (Avidity, Denver, CO). To
prepare dextramers, the biotinylated proteins were mixed with
activated dextran backbones (kindly provided by Immudex,
Copenhagen, Denmark) at a molar ratio of 20:1 in 1 x Tris HCl
0.05 M, pH 7.2, for 30 minutes at room temperature (RT). The
reagents were aliquoted and stored at 4uC until use.
Generation of antigen-sensitized primary T cell cultures
and dextramer staining
Draining lymph nodes (mandibular, axillary and inguinal) were
collected from immunized mice. After the single cell suspensions
were prepared, the lymph node cells (LNC) were stimulated with
the immunizing peptides (PLP 139–151, 20 mg/ml or Myhc 334–
352, 50 mg/ml) at a density of 56106 cells/ml for two days, and
interleukin (IL)-2 medium was then added [21,22,24]. Cells were
stained with dextramers on the indicated days in IL-2 medium,
pH 7.6, containing 2.5% fetal bovine serum at RT for 2 hours,
followed by staining with anti-CD4 (eBioscience, San Diego, CA)
[19]. After cells were washed and fixed with 0.5% PBS-buffered
4% paraformaldehyde, they were examined under the laser
scanning confocal microscope (LSCM). Similarly, PLP 139–151-
specific T cell hybridoma clone (B8) generated in our laboratory
was also stained and examined as above.
Tissue sectioning using vibratome
Cerebrums and hearts were embedded in molten 4% PBS-
buffered low-melting agarose (40uC). To facilitate transverse
sectioning, the cerebrums were embedded with the ventral surface
facing downward, as opposed to the base facing downward for
hearts. The agarose-embedded tissues were patted dry and
mounted onto a vibratome platform, with the ventral surface of
the cerebrum or the base of the heart attached with Loctite super
glue. After tissues were immobilized, the platform was locked in
the vibratome bath filled with cold 16 PBS. A clean razor blade
was attached to the vibratome with the blade angle set at 15u, and
200 mm thick sections were made sequentially at a dead slow speed
‘‘0.22 mm/sec.’’ Sections were then transferred into a 24-well
plate containing cold 16 PBS. For quantitative analysis of
dextramer+ (dext+) cells in the brains, three paired sections were
cut from the dorsal to the ventral surface with a difference of
1.5 mm between pairs. Likewise, eight paired sections were made
continuously from the hearts.
Direct in situ staining with MHC class II/IAs and IAk
dextramers
We performed dextramer staining in 24-well plates. The
cerebral sections were stained individually, but up to three heart
sections were stained together in each well because they were
small. Sections were stained in 300 ml of blocking solution (1 x
PBS/2% normal goat serum) containing dextramer-allophycocya-
nin (APC; 2.5 mg/ml) and anti-CD4-phycoerythrin (PE; 5 mg/ml),
and incubated in the dark at RT for 1.5 hours on a rocking shaker
with gentle rotations. The cocktails of reagents used for cerebral
sections were either IAs/PLP 139–151 dextramers/anti-CD4 or
TMEV 70–86 dextramers/anti-CD4; for hearts they were either
In Situ Detection of Autoreactive CD4 T Cells
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IAk/Myhc 334–352 dextramers/anti-CD4 or RNase 43–56
dextramers/anti-CD4. When staining was complete, the sections
were washed three times with 1 ml cold 1x PBS and incubated at
RT for 10 min on a rocking shaker for each wash. Sections were
then fixed in 1 ml filtered 4% PBS-buffered paraformaldehyde
(pH 7.4) at RT for 1.5 hours, followed by washing three times
with cold 1x PBS as above, and mounted on clean glass slides
using the mounting medium (Dako, Carpinteria, CA).
Laser scanning confocal microscopy
For scanning and acquisition of images, we used the Nikon A1-
Eclipse 90i confocal microscope system (Nikon Instruments Inc-
Americas, Melville, NY). We used two channels to acquire the
images sequentially under high magnification (100x) and their
excitation/emission wavelengths were: 561.5 nm/553–618 nm
laser for pseudocolored ‘‘green’’ channel (CD4-PE); and
640.7 nm/663–738 nm for pseudocolored ‘‘red’’ channel (dex-
tramer-APC). The cells showing co-localization of signals gener-
ated from both the red (dextramers) and green (CD4) channels
were identified as dext+ CD4+ T cells. To quantitatively analyze
dext+ CD4+ T cells, we used the Olympus FV500-BX60 confocal
microscope system (Olympus America Corporation, Central
Valley, PA), in which sequential images were acquired using two
channels: the Cy3 laser (543 nm, pseudocolored ‘‘green’’ for CD4-
PE) and the Cy5 laser (633 nm, pseudocolored ‘‘red’’ for
dextramer-APC). The sequential acquisition involved capturing
images separately, based on the green signal (CD4-PE) followed by
the red signal (dextramers-APC), then merging them. The
quantitative analysis was performed in each mouse using three
sets of paired sections from the cerebrum or eight sets of paired
sections from the heart; one section in each set was stained with
specific or control dextramers together with anti-CD4, and the
sections were examined by LSCM. Initially, the sections were
scanned under low magnification (4x) using the Cy3 laser alone
(for CD4) to locate the spectrum of inflammatory foci across the
surface. We then used both the Cy3 (for CD4) and Cy5 (for
dextramers) lasers under high magnification (100x) to acquire ‘Z’
serial images sequentially at 2 mm intervals. In each cerebral
section, 10 to 15 inflammatory foci were examined, and in each
focus, a set consisting of 15 to 25 serial images was acquired. In
contrast, a total of 20 inflammatory foci representing all eight
sections in the hearts were subjected to ‘Z’ imaging, and 10 to 15
serial images were sequentially acquired from each focus. In all the
images, ‘ImageJ’ software was used to count dext+ CD4+ T cells in
relation to the total number of CD4+ T cells. Finally, the number
of cells in all the ‘Z’ serial images representing three cerebral
sections or eight heart sections were added to obtain the total
number.
Statistical analysis
We used MATLABH (version 8.1.0.604 [R2013a], The
MathWorksTM) for statistical calculations involving cerebral
sections. To compare the differences in dext+ CD4+ cells in the
cerebral sections stained with PLP 139–151 dextramers or TMEV
70–86 dextramers, we used the non-parametric Wilcoxon signed-
rank test. Student’s t-test was used to determine differences in
dext+ CD4+ cells in the heart sections stained with Myhc 334–352
dextramers or RNase 43–56 dextramers. p#0.05 values were
considered significant.
Results and Discussion
Unlike MHC class I tetramers, the use of MHC class II
tetramers for routine applications continues to be challenging,
especially to enumerate the precursor frequencies of low-affinity
autoreactive CD4 T cells, due in part to their activation
dependency [9,25–27]. Recently we circumvented this problem
by creating the next generation of tetramers, called ‘‘dextramers,’’
permitting us to detect antigen-specific CD4 T cells for a number
of autoantigens, such as PLP 139–151, MOG 35–55 and Myhc
334–352 [19]. Additionally, the creation of dextramer reagents
requires a significantly low amount of MHC class II monomers.
Once prepared, the reagents are stable for an extended period of
time at 4uC [19]. Based on these successes, we made efforts to
optimize conditions to detect antigen-specific self-reactive CD4 T
cells in situ by direct staining with the dextramers.
We standardized the reaction conditions for visualization of self-
reactive CD4+ T cells by LSCM using PLP 139–151 dextramers.
Generally, two major factors can negatively influence the detection
of antigen-specific T cells in situ by LSCM. First, insufficient signals
emitted by fluorophores can lead to the need to amplify the signals
using fluorophore antibodies. Second, such an indirect staining
can undermine the specificity, as the background staining for
control reagents also can increase proportionately [28,29]. We
overcame these limitations by direct staining with the dextramers.
We used two cell sources for dextramer staining: (i) PLP 139-151-
sensitized LNCs obtained from immunized animals; and (ii) PLP
139-151-specific T cell hybridoma. Briefly, cells were stained with
PLP 139–151 or TMEV 70–86 (control) dextramers and anti-CD4
as described previously [19]; and after fixation, examined the
dextramer-stained cells by LSCM. Figure 1 shows cells stained
with anti-CD4 alone (left panels, green), with dextramers alone
(middle panels, red) and with the merged CD4 and dextramers
(right panels, yellow/red). As expected, the LNCs or hybridoma
cells that appeared yellow/red in the merged panels also were
stained with anti-CD4 and PLP 139–151 dextramers (Figure 1a
and 1b, top panels). The punctate appearance of dext+ cells may
represent aggregates of multimeric MHC/peptide complexes that
interact with multiple TCRs [30]. Since such staining was lacking
with TMEV 70–86 dextramers (control: Figure 1a and 1b, bottom
panels), the data suggested that the staining obtained with PLP
139–151 dextramers was specific. Thus, the dextramers could be
used to visualize antigen-specific T cells under LSCM by direct
staining without having to amplify the signals with secondary
fluorophore antibodies.
We next sought to determine whether dextramers could be used
to detect antigen-specific T cells in tissues. In brief, freshly cut
cerebral sections were derived from EAE mice and stained with
mixtures containing PLP 139–151 (specific) or TMEV 70–86
(control) dextramers and anti-CD4. The standardization experi-
ments included two parameters, temperature (4uC, 37uC and RT)
and duration of staining (30 min and 1.5 hours). We noted that
the dextramer staining was found to be better at RT than 4u or
37uC with respect to the staining intensity and/or specificity (data
not shown). Since a concentration of 2.5 mg/ml of PLP 139–151
dextramers incubated for 1.5 hours at RT yielded reproducible
detection of PLP-specific CD4 T cells with no or negligible
background staining for control dextramers, we chose these
conditions for further experimentation. As shown in figure 2 (top
panels), the LSCM analysis of brain sections costained with PLP
139–151 dextramers (red) and anti-CD4 (green) revealed the
presence of yellow-colored double positive cells, a feature that was
lacking in sections stained with control (TMEV 70–86) dextramers
(bottom panels). Consistent with the appearance of dext+ CD4+
cells noted in the in vitro-stimulated cultures (Fig 1), the double-
positive cells (dext+ CD4+) in the tissue sections also showed
punctate dots around the surface (Fig 2, insets in the top panels).
Since each dextran-APC molecule in the dextramers contained 9
In Situ Detection of Autoreactive CD4 T Cells
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to 10 MHC/peptide complexes as opposed to a maximum of four
MHC/peptide complexes in conventional tetramers [19], staining
with dextramers might have facilitated cross-linking of MHC/
peptide complexes with multiple TCRs, leading to their enhanced
avidity and better stability of TCR-MHC/peptide complexes.
Such an engagement also may ensure that dextramers cannot be
easily dislodged during a series of washing steps and, as a result,
can be retained at the cell surface for an extended period of time.
Additionally, on a reaction basis, dextramers offer the advantage
of requiring a small amount of MHC/peptide complexes. In our
protocol, each reaction requires only 0.75 mg of MHC/peptide
monomers. Above all, staining with dextramers is a one-step
reaction since dextramers are coincubated with anti-CD4, and the
whole procedure, from tissue sectioning to staining, can be finished
in less than a day. In contrast, the published protocols for in situ
staining with conventional tetramers commonly involve amplifi-
cation procedures in which the fluorescent signals are amplified
using secondary antibodies for fluorophores. As a result, staining
procedures may take up to three days to complete [28,29,33].
To quantitatively analyze the frequencies of antigen-specific T
cells, we then devised a method to count dext+ cells in the multiple
images acquired serially. This analysis involved four steps: 1) As
depicted in figure 3, three paired sections were made from the
cerebrum, and one section from each pair was stained with PLP
139–151 dextramers/anti-CD4, and the other with control
(TMEV 70–86) dextramers/anti-CD4. 2) In each section, 10 to
15 inflammatory foci were located based on staining with CD4
antibody (Fig 3, middle lower panel). 3) Each focus as visualized in
the 3D view (Fig 3, middle upper panel) was subjected to a set of
15 to 25 ‘Z’ serial images, which were captured sequentially from
top to bottom at 2 mm intervals (Fig 3, right panel). Essentially, 10
to 15 such sets of ‘Z’ serial images representing as many
inflammatory foci were analyzed in each section. 4) In each
image, the cells positive for CD4 antibody alone (green) and those
showing colocalization of signals derived from both dextramers
(red) and CD4 (green) and appearing as punctate yellow cells were
counted by marking them separately using ImageJ software.
Finally, a grand total was obtained for each section by adding the
number of cells counted in all the ‘Z’ serial images, as shown in
table 1. Since marking cells eliminated the possibility of recounting
the same cells in multiple overlapping images, dext+ cells could be
reliably enumerated in relation to the total number of CD4 T cells
counted in each section.
The data obtained from three individual mice indicate that the
detection of PLP 139–151 dext+ cells varied between animals
(0.8% to 3.3%) and between sections in each animal (0.8% to
5.5%; Table 1). Such variations were expected, as the inflamma-
tory foci were scattered inhomogeneously across the section.
Nonetheless, by counting the number of cells stained with control
dextramers in parallel sections, we found only one cell out of a
total of 5428 CD4+ cells to be positive for TMEV 70–86
dextramers (0.018%), as opposed to 117 CD4+ T cells found to be
positive for PLP 139–151 dextramers (117/6336 = 1.85%;
p = 0.0078). Based on flow cytometric analysis, we had previously
Figure 1. Evaluation of the specificity of PLP 139–151 dextramers by confocal microscopy in vitro. For dextramer staining, two cell
sources were used: (a) PLP 139-151-sensitized LNCs obtained from immunized mice; and (b) PLP 139-151-specific T cell hybridoma clone (B8). Viable
cells harvested from LNC cultures on day 6 poststimulation, and also hybridoma cells were stained with PLP 139–151 dextramers/anti-CD4 or TMEV
70–86 (control) dextramers/anti-CD4. After washing, cells were fixed with 0.5% paraformaldehyde and examined by LSCM. Top panels (panels, a and
b): cells stained with PLP 139–151 dextramers and anti-CD4. Bottom panels (panels, a and b): cells stained with TMEV 70–86 dextramers (control) and
anti-CD4. Left panels: CD4, green; Middle panels: dextramers, red; Right panels: merged. Dext+ CD4+ T cells are shown with arrows for LNCs, whereas
in PLP 139-151-specific hybridoma cells, the dext+ CD4+ cells are shown as such throughout the field. Original magnification 6006; bar = 20 mm.
doi:10.1371/journal.pone.0087519.g001
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reported detection of similar numbers of PLP 139–151 dext+ cells
(2.3%) in mononuclear cells (MNCs) obtained from the brains of
EAEmice, but the background staining for TMEV 70–86
dextramers also was high (0.7%; [19]). Thus, we have demon-
strated that direct staining with dextramers allows antigen-specific,
self-reactive CD4 T cells to be detected in situ in the brain.
Notably, the use of dextramers has helped us detect antigen-
specific T cells deep in the tissue sections, even up to 50 mm.
However, our attempts to further enhance the detection sensitivity
of dextramers by indirect staining using fluorophore antibodies to
amplify the fluorescent signals yielded a very high background for
Figure 2. Detection of PLP-specific T cells by in situ staining with PLP 139–151 dextramers. EAE was induced in SJL mice by immunizing
the animals with PLP 139–151 in CFA. At termination, cerebrums collected from EAE mice were embedded in 4% agarose, and the sections were
made using vibratome. After staining with cocktails containing either PLP 139–151 dextramers/anti-CD4 or TMEV 70–86 dextramers (control)/anti-
CD4 and fixing with 4% PBS-buffered paraformaldehyde, sections were washed and mounted for examination by LSCM. Top panels: sections stained
with PLP 139–151 dextramers and anti-CD4. Bottom panels: sections stained with TMEV 70–86 dextramers and anti-CD4. Left panel: CD4, green;
Middle panel: dextramers, red; Right panel: merged (circles, dext+ CD4+ T cells; insets represent enlarged views of dext+ CD4+ T cells). Original
magnification 10006; bar = 20 mm.
doi:10.1371/journal.pone.0087519.g002
Figure 3. Quantitative analysis of PLP-specific CD4 T cells detected by in situ staining with PLP 139–151 dextramers in EAEmice.
Three paired cerebral sections, each 200 mm thick, were made from brains obtained from EAEmice using vibratome by cutting the sections from the
dorsal to the ventral surface with 1.5 mm intervals between pairs. One section from each pair was stained with either PLP 139–151 or TMEV 70–86
(control) dextramers together with anti-CD4. After fixing and mounting, the sections were examined by LSCM (60X), and each inflammatory focus was
subjected to a set of ‘Z’ serial images (15 to 25) taken sequentially. In total, 10 to 15 sets of such ‘Z’ serial images representing as many inflammatory
foci were acquired from each section. In all the images, cells positive for both PLP 139–151 dextramers and CD4 or CD4 alone were counted using
‘ImageJ’ software. Finally, the cells counted in all the ‘Z’ serial images obtained from all the inflammatory foci were added to obtain the total number
per section.
doi:10.1371/journal.pone.0087519.g003
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control dextramers leading us to discontinue using this protocol in
our routine experimentation (data not shown).
We further extended the utility of dextramers for in situ
detection of antigen-reactive T cells by adopting the Myhc 334-
352-induced EAM model in A/J mice, in which the disease is
primarily mediated by T cells [31,32]. To evaluate antigen
specificity, we derived LNC cultures from mice immunized with
Myhc 334–352. Using RNase 43–56 dextramers as controls, we
confirmed that Myhc 334–352 dextramer-bound CD4+ T cells
could be visualized by LSCM with specificity (data not shown). We
next analyzed the ability of Myhc 334–352 dextramers to detect
Myhc-reactive T cells in situ, which were expected to infiltrate into
the hearts as we had demonstrated previously by flow cytometry
[19]. To this end, we obtained eight paired sections, each 200 mm
thick, from A/J mice immunized with Myhc 334–352. One section
from each pair (a total of eight sections) were costained with Myhc
334–352 dextramers/anti-CD4; the other set of eight sections
were costained with RNase 43–56 dextramers (control)/anti-CD4.
A total of 20 sets of ‘Z’ serial images representing an equal number
of inflammatory foci from all eight sections were sequentially
acquired as described above. In essence, each set of ‘Z’ serial
images contained 10 to 15 individual images, each representing
one individual focus of inflammation. LCSM analysis of these
images revealed the presence of Myhc 334–352 dext+ cells (red)
colocalized with the expression of CD4 (green) appearing as yellow
cells containing punctae as expected (Fig 4, top panels). By pooling
the dext+ CD4+ cells in all eight sections from each mouse, we
noted frequencies of Myhc 334–352 dext+ cells in the range of
0.92% to 2.0%, as opposed to 0% to 0.09% for control dextramers
Table 1. Quantitative analysis of PLP 139–151-dext+ CD4+ T
cells in the brains of EAE mice by confocal microscopy.
Animal PLP 139–151* TMEV 70–86*
Mouse # 1
Section 1 15/1245 (1.2%) 0/1007 (0%)
Section 2 10/770 (1.4%) 1/1033 (0.097%)
Section 3 3/322 (0.93%) 0/804 (0%)
Total 28/2337 (1.2%) 1/2844 (0.035%)
Mouse # 2
Section 1 13/659 (1.97%) 0/609 (0%)
Section 2 9/689 (1.31%) 0/524 (0%)
Section 3 53/956 (5.5%) 0/937 (0%)
Total 75/2304 (3.3%) 0/2070 (0%)
Mouse # 3
Section 1 11/1370 (0.8%) 0/301 (0%)
Section 2 3/325 (0.92%) 0/213 (0%)
Total 14/1695 (0.8%) 0/514 (0%)
*Number of dext+ CD4+ T cells/total number of CD4+ T cells
doi:10.1371/journal.pone.0087519.t001
Figure 4. Detection of cardiac myosin-specific CD4 T cells by in situ staining. EAM was induced in A/J mice by immunizing the animals with
Myhc 334–352 in CFA; at termination on day 21, hearts were collected after perfusion, and the tissue blocks were prepared using 4% PBS-buffered
agarose. Eight paired sections of 200 mm thickness each were made using vibratome. One section from each pair (a total of eight sections) were
stained with mixtures containing either Myhc 334–352 dextramers/anti-CD4 or RNase 43–56 (control) dextramers/anti-CD4. After fixing with 4% PBS-
buffered paraformaldehyde, the sections were washed and mounted for examination by LSCM. A collage of images showing the cells positive for
both dextramers and CD4 or CD4 alone is shown. Top panels: sections stained with Myhc 334–352 dextramers and anti-CD4. Bottom panels: sections
stained with RNase 43–56 dextramers and anti-CD4. Left panel: CD4, green; middle panel: dextramers, red; right panel: merged. (arrows, dext+ CD4+ T
cells). Original magnification 10006; bar = 20 mm.
doi:10.1371/journal.pone.0087519.g004
Table 2. Quantitative analysis of Myhc 334–352 dext+ CD4+ T
cells in the hearts of EAM mice by confocal microscopy.
Animal Myhc 334–352* RNase 43–56*
Mouse # 1 34/1699 (2.0%) 1/1313 (0.08%)
Mouse # 2 21/2282 (0.92%) 1/1157 (0.09%)
Mouse # 3 26/1571 (1.65%) 0/1128 (0%)
*Number of dext+ CD4+ T cells/total number of CD4+ T cells.
doi:10.1371/journal.pone.0087519.t002
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(1.5260.32% vs. 0.0560.03%, p = 0.01; Table 2). Although the
number of Myhc 334–352 dext+ cells detected by the in situ
technique was marginally lower than the number that could be
detected by flow cytometric analysis of MNCs obtained from
heart-infiltrates (1.52% vs. 2.34%, [19]), the background staining
for control dextramers was negligible with in situ detection (Fig 4;
0.05% vs. 0.34%, [19]). We thus proved the superiority of using
Myhc 334–352 dextramers for reliable quantification of antigen-
specific CD4 T cells in situ. However, in contrast to the signal
intensity obtained with the PLP 139–151 dextramers in cerebral
sections (Fig 2), the signal intensity obtained with Myhc 334–352
dextramers was low in heart sections, possibly due to the
autofluorescence emitted by the heart tissue. This variation may
be due to the structural/anatomical characteristics of tissues in
different organs. For example, CNS tissues contain a high amount
of lipids, whereas heart tissue is predominantly formed by striated
muscle fibers, which may limit the diffusion of dextramers easily
into the infiltrates. Consistent with this notion, we could detect
Myhc 334–352 dext+ cells at a depth only up to 20 mm in most
heart sections. In addition, we noted that Myhc 334–352 dext+
CD4+ T cells were scattered throughout the myocardium,
indicating that the infiltrates were diffuse in myocarditic lesions.
In conclusion, our data indicate that MHC class II dextramers
can be successfully used to detect antigen-specific CD4 T cells in
situ by direct staining. To our knowledge, we are the first to report
the use of MHC class II dextramers to detect autoreactive CD4 T
cells in situ. Furthermore, our method of analyzing antigen-specific
CD4 T cells involves considerably less time – the whole procedure
can be completed in less than a day, as opposed to three days with
previously published protocols [28,29,33]. Additionally, our
protocol requires low amount of starting MHC/peptide complexes
(0.75 mg/reaction), and the dextramers have high degree of
specificity and sensitivity. Although we have successfully demon-
strated the utility of MHC class II dextramers for detection of
antigen-specific CD4 T cells using fresh sections, the utility of these
reagents in detecting cells in frozen tissues remains to be tested.
Such an endeavor can be technically challenging because of
difficulties experienced by other investigators in retaining the
integrity of tissues during staining procedures [28,29].
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